Author Correction: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Main Authors: | Michael A. Crone, Miles Priestman, Marta Ciechonska, Kirsten Jensen, David J. Sharp, Arthi Anand, Paul Randell, Marko Storch, Paul S. Freemont |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18720-1 |
Similar Items
-
A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics
by: Michael A. Crone, et al.
Published: (2020-09-01) -
Author Correction: Building a global alliance of biofoundries
by: Nathan Hillson, et al.
Published: (2019-07-01) -
Building a global alliance of biofoundries
by: Nathan Hillson, et al.
Published: (2019-05-01) -
Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
by: Maximilian Kittel, et al.
Published: (2021-02-01) -
Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
by: Xiuyuan Ou, et al.
Published: (2021-04-01)